Western Blotting Market Trends and Analysis by 2031

The Western Blotting Market size is projected to reach US$ 1,173.73 million by 2031 from US$ 782.42 million in 2023. The market is expected to register a CAGR of 5.2% in 2023–2031. The increasing prevalence of HIV infection and technological advancements in botting systems and government initiatives along with investment by pharma and biotechnology companies is likely to remain key Western Blotting market trends.

Western Blotting Market Analysis

According to the data published by the World Health Organization in 2022, approximately 39 million people are living with HIV of which 6,30,000 people died of Human Immunodeficiency Virus (HIV)-related illness. Hence, the rising prevalence of HIV has led to huge demand for western blotting tests. Western blotting test is always preferred over the enzyme-linked immunosorbent assay (ELISA) test for detecting HIV, owing to its greater accuracy in detecting HIV antibodies in the patient’s blood. However, ELISA is prescribed by healthcare professionals for HIV screening. The technique helps in confirming the HIV infection in the patient’s body. Although this testing tool is much more complicated as compared to ELISA, it delivers more accurate and effective results in detecting HIV.

Western Blotting Market Overview

North America is the largest market for Western Blotting market growth with the US holding the largest market share followed by Canada. Factors such as the increasing prevalence of HIV, increased R&D investment by pharma and biotechnology companies, and increasing application of western blotting technique, which is anticipated to further propel the overall North American Western Blotting market. For instance, in 2021, there were approximately 32,100 estimated new HIV infections in the U.S., however, the Southern US reported the highest percentage of HIV infection i.e. 52%, with approximately 16,700 cases among the newly estimated cases.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Western Blotting Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Western Blotting Market Drivers and Opportunities

Rising Prevalence of HIV Infection Demanding for Western Blotting System Favors the Market

The increasing prevalence of HIV and Lyme disease is contributing to the demand for Western blotting. Western blotting is being used increasingly to effectively differentiate between HIV and other antibodies. For instance, according to the data published by Global HIV & AIDS Statistics, 2021, approximately, 1.5 million people became newly infected with HIV in 2021. A higher prevalence of such diseases requires more diagnostic tests and in turn drives the overall market growth.

Technological Advancements and Demand of Western Blotting from Pharmaceutical and Biotechnology Companies– An Opportunity in Western Blotting Market

Western blotting is a widely known and used test that is used in cell and molecular biology and has gained attraction in the market due to its low cost, specificity, and ease of use. Western blotting manufacturers have marked their presence in the market as there is consistent demand from pharmaceutical and biotechnology companies. Additionally, the research and development activities in the field of proteomics are acting as an additional catalyst for the growth of industrial players in this market.

Protein research dynamics, increased investments in proteomics by biotech and pharmaceutical companies as there is a huge demand for western blotting techniques. Hence, these factors are anticipated to offer lucrative opportunities for the western blotting market growth.

Western Blotting Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Western Blotting Market analysis are product, application, and end users.

• Based on product, the Western Blotting market is segmented into instruments and consumables. The consumables held a larger market share in 2023. The major share can be attributed to the increasing adoption of reagents and consumables for various western blotting procedures.
• By application, the market is segmented into biomedical & biochemical research, agriculture, and others. The biomedical and biochemical research segment held the largest share of the market in 2023. The major share can be attributed to increasing research funding for proteomics and protein-based research.
• By end user, the market is segmented into biotechnological and pharmaceutical companies, diagnostic laboratories, academic and research institutes, and others. The academic and research institutes segment held the major market share in the year 2023. However,  biotechnological and pharmaceutical companies recorded the highest CAGR during the forecast period.

Western Blotting Market Share Analysis by Geography

The geographic scope of the Western Blotting Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the Western Blotting Market. The market growth can be attributed to the rising adoption of Western Blotting for various applications, the rising prevalence of HIV cases, the presence of major manufacturers involved in manufacturing western blotting systems, and the investment by pharma and biotech companies for medical devices in North American countries.

Western Blotting 

Western Blotting Market Regional Insights

The regional trends and factors influencing the Western Blotting Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Western Blotting Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Western Blotting Market Report Scope

Western Blotting Market Players Density: Understanding Its Impact on Business Dynamics

The Western Blotting Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Western Blotting Market are:

1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. GENERAL ELECTRIC
4. Cell Signaling Technology, Inc.
5. PerkinElmer, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Western Blotting Market News and Recent Developments

The Western Blotting Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for western blotting:

• Azure Biosystems Inc. launched the chemiSOLO, a high-performance, personal chemiluminescent imaging system that is compact in size and economical in cost. The chemicals can be controlled by a smartphone, tablet, or laptop through a novel web-based interface, which eliminates the need for investment in a dedicated computer. To support other steps in the Western blotting workflow, chemiSOLO also offers LED lights for visible imaging of samples such as Coomassie-stained gels, colorimetric Western blots, and pre-dyed color protein markers. (Source: Azure Biosystems, Press Release/Company Website/Newsletter, January 2023)
• PerkinElmer, Inc. acquired BioLegend, a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company's existing western blotting product portfolio. (Source: PerkinElmer, Press Release/Company Website/Newsletter, September 2021)
• Bio-Techne Corporation declared that ProteinSimple, a Bio-Techne brand, released its Stellar NIR / IR Detection Modules for Jess.  Stellar fluorescence modules enable the detection of low-abundance proteins while multiplexing multiple analytes within the same detection lane, setting a new industry standard for western blotting fluorescence detection sensitivity.  Multi-color immunoassays can also be run alongside total protein staining using Stellar detection modules. (Source: Biotechne, Press Release/Company Website/Newsletter, Jan 2022)

Western Blotting Market Report Coverage and Deliverables

The “Western Blotting Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles